Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?
Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corp...
| Главные авторы: | ; |
|---|---|
| Формат: | Электронный ресурс Статья |
| Язык: | Английский |
| Проверить наличие: | HBZ Gateway |
| Journals Online & Print: | Загрузка...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Опубликовано: |
Springer Science + Business Media B. V
2010
|
| В: |
Journal of business ethics
Год: 2010, Том: 94, Выпуск: 2, Страницы: 211-224 |
| Другие ключевые слова: | B
direct-to-consumer-advertising (DTCA)
B consumer safety B Pharmaceutical Industry B Corporate social responsibility (CSR) |
| Online-ссылка: |
Presumably Free Access Volltext (JSTOR) Volltext (lizenzpflichtig) |
| Итог: | Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European Union (EU). Doing so results in an alternative analysis of the struggle between proponents and opponents of DTCA from a CSR perspective, adding an alternative view on this debate. |
|---|---|
| ISSN: | 1573-0697 |
| Второстепенные работы: | Enthalten in: Journal of business ethics
|
| Persistent identifiers: | DOI: 10.1007/s10551-009-0257-z |